ACAT Antibodies

Santa Cruz Biotechnology delivers a wide array of ACAT monoclonal antibodies for studying Acyl-CoA:cholesterol acyltransferase (ACAT), a key enzyme involved in cholesterol metabolism. ACAT monoclonal antibodies are effective for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACAT plays a crucial role in the esterification of cholesterol, which is essential for maintaining cellular cholesterol homeostasis and regulating lipid metabolism. Dysregulation of ACAT activity has been implicated in several diseases, including atherosclerosis and neurodegenerative disorders, making it a significant target for therapeutic intervention. Understanding ACAT function through molecular research can provide insights into essential biological processes. Researchers worldwide utilize ACAT monoclonal antibodies to investigate cholesterol metabolism pathways and their impact on various diseases. Advanced research techniques with ACAT monoclonal antibodies enable detailed examination of cellular mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for ACAT research support scientists in advancing our understanding of cholesterol metabolism and its role in human health.